Renal Cell and Renal Pelvis/Ureter Carcinoma

  • Derek C. Allen


Renal Cell and Renal Pelvis/Ureter Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.


Renal Cell Carcinoma Renal Vein Transitional Cell Carcinoma Renal Clear Cell Carcinoma Papillary Renal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Algaba F, Delahunt B, Berney DM, Camparo P, Comperat E, Griffiths D, Kristiansen G, Lopez-Beltran A, Martignoni G, Moch H, Montironi R, Varma M, Egevad L. Handling and reporting of nephrectomy specimens for adult renal tumours: a survey by the European network of uropathology. J Clin Pathol. 2012;65:106–13.PubMedCrossRefGoogle Scholar
  2. Allen DC. Histopathology reporting: guidelines for surgical cancer. 2nd ed. Springer: London; 2006.Google Scholar
  3. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, Venturina MD-P, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. An experience of 405 cases. Am J Surg Pathol. 2002;26:281–91.PubMedCrossRefGoogle Scholar
  4. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma. Am J Clin Pathol. 2009;131:623–30.CrossRefGoogle Scholar
  5. Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nose V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens. Predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30:575–84.PubMedCrossRefGoogle Scholar
  6. Bonsib SM. Macroscopic assessment, dissection protocols and histologic sampling strategy for renal cell carcinomas. Diagn Histopathol. 2008;14(4):151–6.CrossRefGoogle Scholar
  7. Bostwick DG, Cheng L. Urologic surgical pathology. 2nd ed. St. Louis: Mosby/Elsevier; 2008.Google Scholar
  8. Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Histopathology. 2011;58:169–79.PubMedCrossRefGoogle Scholar
  9. Carvalho JC, Thomas DG, McHugh JB, Shah RB, Kunju LP. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology. 2012;60:597–608.PubMedCrossRefGoogle Scholar
  10. Commentary FS. Renal cell carcinoma in acquired cystic kidney disease. Histopathology. 2010;56:395–400.CrossRefGoogle Scholar
  11. D’ Agati VD, Jennette JC, Silva FG. Non-neoplastic kidney diseases, Atlas of nontumor pathology. Washington: AFIP; 2005.Google Scholar
  12. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.Google Scholar
  13. Fleming S. Recently recognized epithelial tumours of the kidney. Curr Diagn Pathol. 2005;11:162–9.CrossRefGoogle Scholar
  14. Fleming S, Griffiths DFR. Nephrectomy for renal tumour; dissection guide and dataset. ACP best practice no 180. J Clin Pathol. 2005;58:7–14.PubMedCrossRefGoogle Scholar
  15. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–63.PubMedCrossRefGoogle Scholar
  16. Griffiths DFR, Vujanic GM. Cystic lesions of the kidney-selected topics. Curr Diagn Pathol. 2002;8:94–101.CrossRefGoogle Scholar
  17. Griffiths DFR, Nind N, O’Brien CJ, Rashid M, Verghese A. Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma. J Clin Pathol. 2003;56:374–7.PubMedCrossRefGoogle Scholar
  18. Kovacs G, Akhtar M. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131–3.PubMedCrossRefGoogle Scholar
  19. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology. 2004;40:460–7.CrossRefGoogle Scholar
  20. Mathers C, Pollock AM, Marsh C, O’Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology. 2002;40:563–7.PubMedCrossRefGoogle Scholar
  21. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder and related urinary structures. Atlas of tumor pathology. 4th series. Fascicle. Washington: AFIP; 2004.Google Scholar
  22. Olgae S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis. A clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28:1545–52.CrossRefGoogle Scholar
  23. Pan C-C, Chen PC-H, Ho DM-T. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology. 2004;45:452–9.PubMedCrossRefGoogle Scholar
  24. Perez-Montiel D, Suster S. Upper urinary tract carcinomas: histological types and unusual morphological variants. Diagn Histopathol. 2007;14:48–54.CrossRefGoogle Scholar
  25. Renshaw AA. Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology. 2002;41:283–300.PubMedCrossRefGoogle Scholar
  26. Sebire NJ, Vujanic VM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2009;54:516–28.PubMedCrossRefGoogle Scholar
  27. Shah RB, Bakshi N, Hafez K, Wood DP, Kunju LP. Image-guided biopsy in the evaluation of renal mass lesions in contemporary urological practice: indications, adequacy, clinical impact and limitations of the pathological diagnosis. Hum Pathol. 2005;36:1309–15.PubMedGoogle Scholar
  28. Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI. Small endoscopic biopsies in the ureter and renal pelvis. Pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.PubMedCrossRefGoogle Scholar
  29. The Royal College of Pathologists. Cancer Datasets (Adult Renal Parenchymal Cancer, Renal Tumours in Childhood, Penile Cancer, Prostatic Carcinoma, Testicular Tumours and Post-Chemotherapy Residual Masses, Tumours of the Urinary Collecting System) and Tissue Pathways (Medical Renal Biopsies, Urological Pathology). Accessed at
  30. Thomas JO, Tawfik OW. Recent advances in the diagnosis of renal cell carcinoma. Diagn Histopathol. 2008;14(4):157–63.CrossRefGoogle Scholar
  31. Thomas DH, Verghese A, Kynaston HG, Griffiths DFR. Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma. Histopathology. 2003;43:374–80.PubMedCrossRefGoogle Scholar
  32. Tickoo SK, de Peralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB. Spectrum of epithelial neoplasms in end-stage renal disease. Am J Surg Pathol. 2006;30:141–53.PubMedCrossRefGoogle Scholar
  33. Trpkov K, Yilmaz A, Uzer D, Dishongh KM, Quick CM, Bismar TA, Gokden N. Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology. 2010;57:892–906.CrossRefGoogle Scholar
  34. Veeratterapillay R, Simren R, El-Sherif A, Johnson MI, Soomro N, Heer R. Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England. J Clin Pathol. 2012;65:367–71.PubMedCrossRefGoogle Scholar
  35. Venturina MD-P, Moch H, Amin M, Tamboli P, Hailemarian S, Mitatsch M, Javidan J, Stricker H, Ro JY, Amin MB. Sarcomatoid differentiation in renal cell carcinoma. A study of 101 cases. Am J Surg Pathol. 2001;25:275–84.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Derek C. Allen
    • 1
  1. 1.Histopathology LaboratoryBelfast City HospitalBelfastUK

Personalised recommendations